Stryker Corporation (SYK)
Return on equity (ROE)
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 3,246,000 | 2,943,000 | 2,918,000 | 2,859,000 | 2,993,000 | 3,590,000 | 3,448,000 | 3,361,000 | 3,165,000 | 2,585,000 | 2,709,000 | 2,627,000 | 2,358,000 | 2,457,000 | 2,079,000 | 2,015,000 | 1,994,000 | 1,900,000 | 2,083,000 | 1,408,000 |
| Total stockholders’ equity | US$ in thousands | 22,420,000 | 21,785,000 | 21,191,000 | 20,930,000 | 20,634,000 | 20,149,000 | 19,762,000 | 19,172,000 | 18,593,000 | 17,905,000 | 17,361,000 | 16,895,000 | 16,616,000 | 16,463,000 | 15,674,000 | 15,046,000 | 14,877,000 | 14,178,000 | 13,820,000 | 13,502,000 |
| ROE | 14.48% | 13.51% | 13.77% | 13.66% | 14.51% | 17.82% | 17.45% | 17.53% | 17.02% | 14.44% | 15.60% | 15.55% | 14.19% | 14.92% | 13.26% | 13.39% | 13.40% | 13.40% | 15.07% | 10.43% |
December 31, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $3,246,000K ÷ $22,420,000K
= 14.48%
Peer comparison
Dec 31, 2025
Company name
Symbol
ROE
Stryker Corporation
SYK
14.48%
Abbott Laboratories
ABT
27.43%
CONMED Corporation
CNMD
6.35%